Cronos Group Inc. (CRON) vs Harrow, Inc. (HROW)
- Cronos Group Inc. CRON 3.22 +0.63%
- Harrow, Inc. HROW 27.28 −5.11%
Cronos Group Inc. and Harrow, Inc. are both Drug Manufacturers Specialty & Generic companies. Cronos Group Inc. and Harrow, Inc. are of similar size ($1.2B and $1.1B). Harrow, Inc. has negative trailing earnings, so its P/E is not meaningful; Cronos Group Inc. trades at 16.1×. Cronos Group Inc. grew revenue faster over the last twelve months: 37.5% against 21.1%. Cronos Group Inc. has the higher net margin (20.9% vs −13.5%) and the higher return on invested capital (−0.34% vs −0.77%). Across the 19 metrics below, Cronos Group Inc. leads on 14 and Harrow, Inc. on 5.
Valuation
Profitability
| Metric | CRON | HROW | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 45.86% | 73.28% | 53.94% |
| Operating margin | (0.96%) | (1.00%) | 0.00% |
| Net margin | 20.91% | (13.51%) | 0.00% |
| Free cash flow margin | 27.61% | (4.75%) | 0.00% |
| Return on equity | 3.33% | (116.07%) | (0.40%) |
| Return on assets | 3.18% | (9.77%) | (3.32%) |
| Return on invested capital | (0.34%) | (0.77%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack